Common name
imidazole-2,4-dione
IUPAC name
imidazole-2,4-dione
SMILES
O=C1NC(=O)N=C1
Common name
imidazole-2,4-dione
IUPAC name
imidazole-2,4-dione
SMILES
O=C1NC(=O)N=C1
INCHI
InChI=1S/C3H2N2O2/c6-2-1-4-3(7)5-2/h1H,(H,5,6,7)
FORMULA
C3H2N2O2
Common name
imidazole-2,4-dione
IUPAC name
imidazole-2,4-dione
Molecular weight
98.060
clogP
0.744
clogS
-0.271
Frequency
0.0021
HBond Acceptor
2
HBond Donor
1
Total PolarSurface Area
58.53
Number of Rings
1
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00140 | Phenytoin |
|
Anticonvulsants; Voltage-Gated Sodium Channel Blockers; Nervous System; Antiepileptics; Hydantoin Derivatives; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP3A4 Inhibitors; | For the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal lobe) seizures and prevention and treatment of seizures occurring during or following neurosurgery. |
| FDBD00563 | Nitrofurantoin |
|
Anti-Infective Agents; Anti-Infective Agents, Urinary; Antibacterials for Systemic Use; Antiinfectives for Systemic Use; Nitrofuran Derivatives; | May be used as an alternative in the treatment of urinary tract infections. May be used by females pericoitally for prophylaxis against recurrent cystitis related to coitus. |
| FDBD00618 | Ethotoin |
|
Anticonvulsants; Nervous System; Antiepileptics; Hydantoin Derivatives; Cytochrome P-450 CYP2C19 Inducers; | For the control of tonic-clonic (grand mal) and complex partial (psychomotor) seizures. |
| FDBD01065 | Dantrolene |
|
Muscle Relaxants, Central; Musculo-Skeletal System; Muscle Relaxants; Dantrolene and Derivatives; Muscle Relaxants, Directly Acting Agents; CYP3A4 Inhibitors; | For use along with appropriate supportive measures for the management of the fulminant hypermetabolism of skeletal muscle characteristic of malignant hyperthermia crises in patients of all ages. Also used preoperatively, and sometimes postoperatively, to prevent or attenuate the development of clinical and laboratory signs of malignant hyperthermia in individuals judged to be malignant hyperthermia susceptible. |
| FDBD01128 | Fosphenytoin |
|
Anticonvulsants; Nervous System; Antiepileptics; Hydantoin Derivatives; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP3A4 Inhibitors; | For the control of generalized convulsive status epilepticus and prevention and treatment of seizures occurring during neurosurgery. It can also be substituted, short-term, for oral phenytoin. |
| FDBD02274 | imiprothrin |
|
Insecticide | Insecticide |
6 ,
1
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 4d1c_ligand_frag_0.mol2 | 4d1c | 1 | -6.18 | N1=CC(=O)NC1=O | 7 |
| 4d1b_ligand_frag_0.mol2 | 4d1b | 1 | -6.12 | N1=CC(=O)NC1=O | 7 |
| 4d1d_ligand_frag_0.mol2 | 4d1d | 1 | -6.06 | N1=CC(=O)NC1=O | 7 |
| 4d1a_ligand_frag_2.mol2 | 4d1a | 1 | -5.99 | C1=NC(=O)NC1=O | 7 |
| 4wke_ligand_frag_3.mol2 | 4wke | 1 | -5.54 | C1(=O)C=NC(=O)N1 | 7 |
| 4wki_ligand_frag_3.mol2 | 4wki | 1 | -5.49 | C1(=O)NC(=O)C=N1 | 7 |
| 4ih6_ligand_frag_0.mol2 | 4ih6 | 1 | -5.48 | N1C(=O)N=CC1=O | 7 |
100 ,
11
